News - Page 282 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

New York Times runs an article on VC interest in psychedelic medicines, including psilocybin

Post published:March 6, 2020
Post category:News

Read more about the article YIELD GROWTH Subsidiary Flourish Mushroom Labs Files for U.S. Patent to use Serotonin Agonists from Psychedelic Mushrooms for Weight Loss

YIELD GROWTH Subsidiary Flourish Mushroom Labs Files for U.S. Patent to use Serotonin Agonists from Psychedelic Mushrooms for Weight Loss

Post published:December 10, 2019
Post category:Press Release

CB Therapeutics Achieves Major Breakthrough in the Biosynthesis of Psilocybin, Psilocin and Related Tryptamine-based Compounds

Post published:December 4, 2019
Post category:Press Release

End of content

No more pages to load

Newer Posts

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.